It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.1, 1.62, 0.72, and 3.3%, respectively.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11426858 | PMC |
http://dx.doi.org/10.4103/jpbs.jpbs_5_24 | DOI Listing |
Am J Gastroenterol
November 2024
Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Assoc Physicians India
November 2024
Professor, Mahatma Gandhi Hospital, Jodhpur, Rajasthan, India.
Aliment Pharmacol Ther
January 2025
Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background: Coeliac disease (CD) is common in patients with type 1 diabetes (T1D), but prevalence varies globally due to differing screening protocols. There have been substantial changes in screening guidelines over the past two decades.
Aim: To evaluate CD prevalence in patients with T1D, focusing on screening studies using antitissue transglutaminase (anti-tTG) antibody.
J Pharm Bioallied Sci
July 2024
Department of Orthodontics, PGIDS, Rohtak, Haryana, India.
It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.
View Article and Find Full Text PDFDig Liver Dis
September 2024
Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.
Background: Celiac disease (CeD) is an immune-mediated disorder affecting the small bowel, associated with genetic factors and increasing global prevalence.
Aim: This study explores the association between CeD, Systemic Lupus Erythematosus (SLE), primary Sjogren syndrome (pSS), and Systemic Sclerosis (SSc).
Methods: A systematic review and meta-analysis were conducted following PRISMA guidelines.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!